维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="Holyoake TL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Effective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src/Abl kinase inhibitor SKI-606 显示文摘	Konig H Holyoake TL Bhatia R	2008	Blood2008，11，4：	1
2	Targeting survival pathways in chronic myeloid leukaemia stem cells显示文摘	Sinclair A Latif AL Holyoake TL	2013	Br J Pharmacol2013，169，8：	1
3	Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia显示文摘	Holyoake TL Jiang X Drummond MW	2002	Leukemia2002，16，4：	1
4	Is there a cloud in the silver lining for imatinib? 显示文摘	Paterson SC Smith KD Holyoake TL	2003	Br J Cancer2003，88，：	1
5	Concise Review: Cancer Cells Escape from Oncogene Addiction: Understanding the Mechanisms Behind Treatment Failure for More Effective Targeting 显示文摘	PELLICANO F MUKHERJEE L HOLYOAKE TL	2014	Stem Cells2014，32，6：	1
6	Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice显示文摘	Nicolini FE Holyoake TL Cashman JD Chu PP Lambie K Eaves CJ	1999	Blood1999，94，8：	1
7	Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow 显示文摘	Holyoake TL Nicolini FE Eaves CJ	1999	Exp Hematol1999，27，9：	1
8	Omacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem/progenitor cells显示文摘	Allan EK Holyoake TL Craig AR	2011	Leukemia2011，25，6：	1
9	Elucidating critical mechanisms of deregulated stem cellturnover in the chronic phase of chronic myeloid leukemia显示文摘	Holyoake TL Jiang X Drummond MW		0，，：	1
10	Improved ex vivo expansion of CD^34 selected PBPC using high expansion culture bags 显示文摘	Alcom MJ Holyoake TL Richmond LJ	1996	Br J Haematol1996，93，1：	1
11	Recent advances in the molecular and cellular biology of chronic myeloid leukemia:lessons to learned from the laboratory显示文摘	Holyoake TL	2011	Br J Haematol2011，113，1：	1
12	Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression ofinterleukin-3显示文摘	Holyoake TL Jiang X Jorgensen HG		0，，：	1
13	Targeting survival pathways in chronic myeloid leukaemia stem ceils 显示文摘	Sinclair A Latif AL Holyoake TL	2013	Br J Pharmacol2013，169，8：	1
14	T Targeting chronic mye- loid leukemia stem cells 显示文摘	Helgason GV Young GA Holyoake TL	2010	Curr Hematol Malig Rep2010，5，2：	1
15	TheraPeutic targets in chronic myeloid Ieukaemla显示文摘	Heaney NB Holyoake TL	2007	Hematol oncoi2007，25，2：	1
16	Characterization of cancerstem cells in chronic myeloid leukemia显示文摘	Jorgensen HG Holyoake TL	2007	Biochem SocTrans2007，35，5：	1
17	Evolution of bone marrow transplantation the original immunotherapy 显示文摘	Campbell J Cook G Holyoake TL	2001	J Immunol Today2001，22，2：	1
18	Optimising chronicmyeloid leukemia therapy in the face of resistance to tyrosine kinase inhibitors-a synthesis of clinical and laboratory data显示文摘	Irvine DA Heaney NB Holyoake TL	2010	Blood Rcv2010，24，1：	1
19	A comparison of normal and leukemic stem cell biology in chronic myeloid leukemia 显示文摘	Jorgensen HG Holyoake TL	2001	Hematol Oncol2001，19，1：	1
20	Is there a cloud in the silver lining for imatinib?显示文摘	Paterson SC Smith KD Holyoake TL	2003	Br J Cancer2003，88，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示